Biomarkers uPA/PAI-1 in breast cancer: Benefit, harm of test unclear
Adjuvant systemic treatments aim to prolong survival Even if the breast cancer was completely removed in surgery, the tumour can come back. The risk of such a recurrence can be low, intermediate or high. Adjuvant systemic treatments including chemotherapy are used to lower the risk of recurrence and prolong survival. …